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Abstract
A novel broad-spectrum antimicrobial peptide produced by vegetable-associated Enterococcus mundtii was purified and
characterized, and designated mundticin. To our knowledge, this is the first report on bacteriocin production by this
organism. The elucidation of the full primary amino acid sequence of mundticin (KYYGNGVSCNKKGCSVDWGKAI-
GIIGNNSAANLATGGAAGWSK) revealed that this antimicrobial peptide belongs to the class IIa bacteriocins of lactic
acid bacteria which share a highly conserved N-terminal ‘YGNGV’ motif. Data obtained by computer modelling indicated
an oblique orientation of the K-helical regions of mundticin and homologous class IIa bacteriocins at a hydrophobic^
hydrophilic interface, which may play a role in the destabilization of phospholipid bilayers. The average mass of mundticin,
as determined by electron spray mass spectrometry, was found to be 4287.21 þ 0.59 Da. With respect to its biological activity,
mundticin was shown to inhibit the growth of Listeria monocytogenes, Clostridium botulinum and a variety of lactic acid
bacteria. Moreover, it was demonstrated to have a bactericidal effect on L. monocytogenes as a result of the dissipation of the
membrane potential, and a loss of intracellular ATP in absence of ATP leakage. Its good solubility in water, and its stability
over a wide pH and temperature range indicate the potential of this broad spectrum bacteriocin as a natural preservation
agent for foods. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Bacteriocins are antimicrobial peptides and pro-
teins that are ribosomally synthesized by bacteria
[1]. These compounds can inhibit or eliminate the
growth of target organisms by a¡ecting the mem-
brane permeability [2,3], or by interfering with essen-
tial cell functions such as DNA replication [4] and
translation [5]. Traditionally, bacteriocin research
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has focussed on proteins of Gram-negative bacteria
[6]. However, bacteriocins produced by Gram-posi-
tive organisms, particularly those from lactic acid
bacteria (LAB), have recently provoked a great
deal of interest for their potential as non-toxic pre-
servatives in the food and feed industry [7]. Four
classes of LAB bacteriocins can be distinguished
[8], with the class I and II bacteriocins being by far
the most abundant and best characterized. Members
of these two classes are small, heat-stable peptides of
a cationic and hydrophobic nature. Their antimicro-
bial activity generally seems to be related to the for-
mation of pores in the cytoplasmic membrane of
target cells, which is thought to involve binding of
monomers to the membrane, followed by insertion
into the membrane and aggregation of monomers
to form water-¢lled pores. This process explains the
death of target organisms due to the leakage of small
intracellular components and the dissipation of the
proton motive force [9^11].
The molecular mechanisms by which class I and II
bacteriocins of LAB act, appear to di¡er consider-
ably. Detailed studies of class I bacteriocins, which
typically contain post-translationally modi¢ed amino
acids (lanthionines), demonstrated that these com-
pounds act in a membrane potential dependent way
in absence of a protein-receptor [3,12]. By contrast,
class II bacteriocins, which do not contain modi¢ed
amino acids, are believed to interact with membrane
receptor proteins prior to insertion into the cytoplas-
mic membrane in a voltage-independent way [11,13].
Within the latter class of bacteriocins, particular at-
tention has been paid to members of the subclass IIa,
mainly because of their activity toward the pathogen
Listeria monocytogenes. The class IIa bacteriocins are
characterized by the presence of a N-terminal con-
sensus sequence ‘Tyr-Gly-Asn-Gly-Val’ (YGNGV)
[8,14]. This highly conserved N-terminal region has
been suggested to form part of a recognition se-
quence for a putative membrane-bound protein re-
ceptor [15,16]. However, it was recently demon-
strated that a prominent member of this class,
pediocin PA-1, can function in absence of a protein
receptor [17].
The initial steps in pore formation by bacteriocins
involve: (1) electrostatic interactions between the
positively charged and polar residues of the peptide
and the head groups of the phospholipids in the bi-
layer; and (2) hydrophobic interactions between the
hydrophobic residues of the peptide and the lipid
acyl chains [16,18,19]. Importantly, class IIa bacter-
iocins are predicted to contain K-helical regions with
a varying amount of hydrophobicity [8,10], which are
thought to play a key role in the interaction with the
lipid bilayer [16]. Experimental evidence for the pres-
ence of an K-helical region in lipophilic environments
was recently reported for the class IIa bacteriocin
leucocin A, upon elucidation of its three-dimensional
structure [20]. However, the structural and functional
properties of complexes of the K-helical regions of
the class IIa bacteriocins and lipid bilayers are un-
known.
A recent classi¢cation of lipid-associating K-helices
distinguishes between lipid-associated peptides with a
constant hydrophobicity, and peptides with a hydro-
phobic gradient along the axis of their K-helix
[18,21]. Peptides of the former category have been
found to interact with lipid bilayers through helical
structures which are positioned parallel or perpendic-
ular to the hydrophobic^hydrophilic interface. Con-
versely, oblique peptides with a hydrophobicity gra-
dient along their axis insert at a 30^60‡ angle into
hydrophobic/hydrophilic interfaces. Such peptides
have been identi¢ed in processes in which membrane
perturbation underlies the action of the peptide (re-
cently reviewed in [18]). These processes include a
wide range of biological phenomena, such as cell
signalling events [22], fusion events that are induced
by viral peptides [23,24] or the Alzheimer L-amyl-
oid peptide [25], and processes in lipid metabolism
[18].
The objective of this study was to characterize the
compound that is responsible for the antimicro-
bial activity of a vegetable-associated strain of Ente-
rococcus mundtii. This compound was identi¢ed
as the novel bacteriocin mundticin, and its action
on the cytoplasmic membrane of sensitive cells
was demonstrated. We furthermore examined the
orientation of the K-helical region of mundticin
and homologous bacteriocins at a hydrophobic^
hydrophilic interface by means of computer mod-
elling.
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2. Materials and methods
2.1. Bacterial strains and culturing conditions
In a search for bacteriocinogenic LAB from min-
imally processed vegetables, we obtained three bac-
teriocin-producing LAB with activity toward L.
monocytogenes, out of a total of 900 isolates as de-
scribed previously [26]. Two strains were identi¢ed as
Pediococcus parvulus [26]. The third strain was iso-
lated from fresh chicory endive and preliminarily
identi¢ed as Enterococcus strain ATO6 by the use
of API Rapid CH fermentation strips (BioMerieux,
Marcy d’Etoile, France). Full characterization by the
services of the Deutsche Sammlung von Mikroorga-
nismen (DSM, Braunschweig, Germany) identi¢ed
this strain as E. mundtii on the basis of fermentation
patterns and 16S rRNA analysis. Lactobacillus sake
DSM 20017 was used as an indicator strain for the
monitoring of bacteriocin activity. E. mundtii ATO6
and L. sake DSM 20017 were routinely grown in
MRS medium (Oxoid, Basingstoke, UK). L. mono-
cytogenes LDCD81-861 [27] (kindly provided by Dr.
Nguyen-The, Institut Nationale de la Recherche
Agronomique, France) was grown in brain heart in-
fusion (BHI) broth (Oxoid) supplemented with 0.5%
(w/v) glucose. All cultivations were started with 1%
inocula and performed at 30‡C.
2.2. Bacteriocin assays, antimicrobial spectrum and
stability
The antimicrobial activity of mundticin was deter-
mined in a microtiter assay as previously described
[26]. Hereby, the activity was expressed in bacteriocin
units (BU) per ml, which was calculated from the
reciprocal of the highest dilution of a sample that
reduced the OD660 of the indicator organism by
50% after 8 h of incubation at 30‡C. This assay
was also used to determine the minimally inhibitory
concentration (MIC) of mundticin against L. mono-
cytogenes LDCD81-861, starting from a puri¢ed bac-
teriocin solution with a known bacteriocin concen-
tration.
To determine the nature of the inhibitory sub-
stance, the supernatant of E. mundtii ATO6 was
treated with proteolytic enzymes, i.e. trypsin, K-chy-
motrypsin and proteinase K (1 mg/ml) (Boehringer,
Mannheim, Germany) for 2 h at 37‡C. The pH
stability of the puri¢ed bacteriocin during storage
at 4‡C for 14 h was determined in the range of pH
1^12 with 1 pH unit intervals. Following incubation,
the antimicrobial activity of the samples was deter-
mined by the use of the microtiter assay as described
above. The heat resistance was assessed by boiling a
bacteriocin solution which was adjusted to pH 6.0
for 1, 5, 10, 15, 30 or 60 min. Again, the remaining
bacteriocin activity was measured by the use of the
microtiter assay.
Growth inhibition of a panel of 65 bacteria and
fungi (listed in [26]) in response to culture superna-
tant of E. mundtii was determined by the use of a
well di¡usion assay and a microtiter assay as de-
scribed previously [26]. To establish whether the ac-
tion of mundticin was bacteriostatic or bactericidal,
late-exponential-phase cells of L. monocytogenes
LCDC81-681 in BHI broth were exposed to this bac-
teriocin (¢nal concentrations 0.1 and 1.0 Wg/ml) and
after dilution of the cells, the viable counts were de-
termined at regular time intervals during 5 h at 30‡C.
2.3. Puri¢cation of mundticin
The bacteriocin produced by E. mundtii ATO6 was
isolated from 2 l of a 22 h static culture (grown in
MRS broth (Oxoid) at 30‡C). The cells were re-
moved by centrifugation, and proteins were subse-
quently concentrated from the supernatants by a
two-step ammonium sulfate precipitation (0^25%
and 25^70% saturation). The fraction obtained
from the second step of this precipitation was dis-
solved in 50 mM 2-(N-morpholino)ethanesulfonic
acid (MES) bu¡er, pH 5.5, containing 0.85 M am-
monium sulfate. Aliquots (3 ml) were loaded on a
24-ml phenyl Sepharose CL4B column (Pharmacia,
Uppsala, Sweden) which was equilibrated with 0.42
M ammonium sulfate in 50 mM MES bu¡er, pH 5.5.
The elution was performed by a 140 min linear gra-
dient from 0.42 to 0.0 M ammonium sulfate in 50
mM MES bu¡er, pH 5.5, at 2 ml/min. The most
active fractions were pooled, diluted ¢ve-fold in 10
mM formic acid^10% EtOH (solution A), and loaded
on a 1 ml Resource S cation-exchange column (Phar-
macia) which was equilibrated with solution A. The
column was eluted with a 30 min linear gradient
from 0.0 to 1.0 M NaCl in 10 mM formic acid^
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10% EtOH at 5 ml/min. The active fractions were
pooled, and further puri¢cation was accomplished
by loading 50 Wl samples on a Superdex Peptide
PC3.2/30 gel ¢ltration column (Smartsystem, Phar-
macia), followed by elution in 0.15 M NaCl^0.1%
tri£uoroacetic acid (TFA)^20% EtOH at 80 Wl/min
(monitoring at 214, 254, and 280 nm). The homoge-
neity of the peaks was con¢rmed by reversed phase
chromatography with a C2^C18 WRPC 3.2/30 column
(Pharmacia) using a 30 min linear gradient from 20
to 95% EtOH in 0.1% TFA (100 Wl/min, monitoring
at 214 nm).
2.4. Enzymatic cleavage and alkylation of mundticin
Puri¢ed mundticin (40 Wg/ml in 50 mM Tris^HCl,
pH 7.4) was incubated with the sequence grade en-
doprotease Asp-N (Boehringer) at an enzyme to sub-
strate ratio of 1:20 (w/w). After incubation for 7 h at
37‡C, the reaction was stopped by the addition of
trichloroacetic acid (TCA) (5% ¢nal concentration).
The peptide fragments were immediately separated
by injection of 50 Wl samples on a Superdex Peptide
PC3.2/30 gel ¢ltration column (Pharmacia), using the
same conditions as described above. Reduction and
alkylation of puri¢ed mundticin were performed by
dissolving the peptide in 0.2 M Tris^6 M guanidine^
HCl bu¡er, pH 8.4, containing 20 mM DTT. After
incubation for 1 h at 20‡C, 1 Wl of 4-vinylpyridine
was added. This reaction mixture was further incu-
bated for 1 h at 20‡C, after which the sample was
diluted (1:1 in water) and sequenced.
2.5. N-terminal amino acid sequence analysis and
mass spectrometry
Puri¢ed peptides were analyzed by the Sequence
Center Utrecht (University of Utrecht, Utrecht,
The Netherlands). The N-terminal sequences were
obtained by Edman degradation on an automated
gas phase sequencer (Applied Biosystems model
476A) with on-line phenylthiohydantoin derivate
identi¢cation by reversed phase chromatography on
HPLC. Electronspray-mass spectrometry (ES-MS)
was performed at the Institute for Animal Science
and Health (ID-DLO, The Netherlands). The mass
spectrum of puri¢ed peptides was determined by di-
rect injection (1.2 Wg/Wl in 0.1% TFA^50% EtOH) on
a Quattro IISQ instrument (Micromass, Manchester,
UK).
2.6. Measurement of the membrane potential with
£uorescent probe
Cells of L. monocytogenes LDCD81-861 were har-
vested in the exponential phase of growth (OD660 0.6)
by centrifugation (5000Ug, 15 min) at 4‡C, washed
twice in 50 mM potassium N-2-Hydroxyethyl-
piperazine-NP-2-ethane-sulfonic acid (K-HEPES)
bu¡er (pH 7.0), resuspended in this bu¡er (to
approximately 1/50 of the original culture volume),
and stored on ice until use. Membrane potential
(vi) measurements were performed by using the
£uorescent probe 3,3-dipropylthiocarbocyanine
(DiSC35). Cell suspensions were diluted in the
K-HEPES bu¡er to a density of 0.06 mg bacterial
protein/ml. Reactions were performed at 20‡C in a
Perkin Elmer LS 50B spectro£uorometer, and the
vi was monitored with DiSC35 (excitation wave-
length, 643 nm; emission wavelength, 666 nm) at a
¢nal concentration of 5 WM. The was generated after
the addition of glucose in the presence of the H/K
exchanger nigericin (¢nal concentrations of 0.2% w/v
and 5 WM, respectively). After reaching a steady-state
vi, the puri¢ed mundticin was added to the cells. The
K ionophore valinomycin (¢nal concentration 2
WM) was used as a control for the absence of a mem-
brane potential. Protein concentrations of bacteriocin
preparations were determined with the NanoOrange
Protein Quantitation kit (Molecular Probes Europe),
using bovine serum albumin as a standard.
2.7. Measurement of ATP concentrations
To determine the in£uence of mundticin on the
intracellular and extracellular ATP concentrations
of L. monocytogenes LDCD81-681, cell suspensions
were prepared essentially as described above for the
vi measurements, however, with the use of 50 mM
potassium phosphate (KPi) bu¡er (pH 7.0). Cell sus-
pensions were diluted in this KPi bu¡er (0.10 mg
bacterial protein/ml) and incubated for 6 min at
30‡C with glucose (¢nal concentration of 0.5%, w/
v), prior to the addition of puri¢ed mundticin (¢nal
concentrations of 0.14 Wg/ml). At regular time inter-
vals, 0.2 ml samples of the suspensions were re-
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moved, and the cells were immediately separated
from the external medium by spinning them through
a layer of silicon oil, which was placed on top of a
layer of 50 Wl 10% (w/v) TCA with 2 mM EDTA
[28]. Aliquots (5 Wl) of both aqueous layers were
used to determine the ATP content using the ¢re£y
luciferase assay as described previously [29]. Lumi-
nescence was recorded using a BIO-Orbit 1250 lu-
minometer (Turku, Finland). Protein concentrations
of bacterial cell suspensions were determined and by
the method of Lowry et al. [30], using bovine serum
albumin as a standard.
2.8. Identi¢cation of an oblique-orientated peptide and
molecular modelling of peptide insertion into the
lipid bilayer environment
The search for an oblique-orientated helical pep-
tide in mundticin and other class IIa bacteriocins was
carried out by scanning the entire bacteriocin sequen-
ces according to the procedure of Rahman et al. [31].
The hydrophobicity gradient for a 12^13 residue pep-
tide window along the di¡erent bacteriocin sequences
was calculated according to the method of Ja«hnig
[32], taking into account the mean hydrophobicity
(Ho) of the peptide and its hydrophobic moment
(WH), which is a measure for the amphiphilic nature
of the peptide, using the Eisenberg’s hydrophobicity
scale [33]. Any helical peptide with an Ho of v0.2
and a hydrophobicity gradient along the axis of the
helical peptide between the C-terminal and N-termi-
nal end was considered as an acceptable candidate.
Modelling of all peptides was carried out as de-
scribed previously [21] and the method used is that
applied to the study of amphiphilic molecule confor-
mation [34]. The method used for the prediction of
the conformational structure of the peptides ac-
counted for the contribution of classic energy (Van
der Waals, electrostatic and hydrophobic binding en-
ergy) as well as the lipid^water interface properties,
including the concomitant variation of the dielectric
constant and the transfer energy of atoms from a
hydrophobic to a hydrophilic environment [35]. The
structure, mode of insertion, and orientation of the
peptides were predicted as in a hydrophobic^hydro-
philic interface. In this model, the interaction energy
was calculated and minimized until the lowest energy
state of the entire peptide^lipid aggregate was
reached. All calculations were performed on a Pen-
tium Pro processor station, by using PC-TAMMO+
(Theoretical Analysis of Molecular Membrane Or-
ganization) and PC-PROT+ (Protein Plus Analysis)
software. Graphs were drawn with the WINMGM
program.
2.9. Accession number
The amino acid sequence of mundticin determined
in this study has been deposited in the SwissProt
database under accession number P80925.
3. Results
3.1. Characterization and puri¢cation of mundticin
A lactic acid bacterium with a broad spectrum of
antimicrobial activity was isolated from fresh chicory
endive and identi¢ed as E. mundtii ATO6. The super-
natant of E. mundtii ATO6 cultures exhibited strong
antimicrobial activity against the indicator strain L.
Fig. 1. Gel ¢ltration elution pro¢le of (A) puri¢ed mundticin
and (B) mundticin cleaved with Asp-N on a Superdex Peptide
PC3.2/30 column. Peak i, amino acids 1^43 (full length mundti-
cin); peak ii, amino acids 17^43 of mundticin; peak iii, amino
acids 1^16 of mundticin.
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sake DSM 20017, which reached a maximum after
approximately 22 h of growth, yielding 2.6U106 BU/
l culture £uid. Proteolytic treatment of the superna-
tant resulted in total loss of this activity, indicating
the proteinaceous nature of the antimicrobial com-
pound. After a two-step ammonium sulfate precipi-
Table 1
Multiple sequence alignment of mundticin to bacteriocins produced by lactic acid bacteria containing a YGNGV amino acid motif
Multiple sequence alignments were performed using the Clustal program with a ¢xed gap penalty. Gaps (-) were introduced to opti-
mize alignments. The percentages of identity and homology are calculated by taking the inserted gaps into account. Identical (*) and
(W) similar residues are indicated. The homology score and similarity score were calculated according to Higgins and Sharp [42].
Fig. 2. Electronspray mass spectrum of mundticin with multiple charged molecular ions.
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tation of the supernatant, with near total recovery of
bacteriocin activity (99%) in the second step, the
antimicrobial compound was puri¢ed to homogene-
ity by chromatographic techniques. Hydrophobic in-
teraction chromatography and subsequent cationic
exchange chromatography gave 60 and 55% recovery
of the initial activity, respectively. A single peak
eluted from the gel ¢ltration column (95% yield of
activity) (Fig. 1), which homogeneity was con¢rmed
by reversed phase chromatography. The speci¢c ac-
tivity of the puri¢ed peptide against L. sake was 1500
BU/Wg, and the ¢nal yield of the peptide from the
culture supernatant was 0.5 mg/l. The antimicrobial
activity of the peptide was not a¡ected by heating for
15 min at 100‡C, but prolonged heating for 1 h at
100‡C resulted in a 50% loss of activity. The peptide
was stable from pH 1 to 10 for 14 h at 4‡C.
N-Terminal amino acid sequence analysis of the
puri¢ed bacteriocin revealed a 43 amino acid (aa)
residue peptide, which was designated mundticin. In-
itial sequence analysis did not identify the residues at
positions 9 and 14 and the residues at positions 37
and 40^43 could not unequivocally be appointed. To
fully elucidate the primary structure of the bacterio-
cin, the peptide was cleaved with Asp-N speci¢c en-
doprotease. The two resulting fragments were sepa-
rated by gel ¢ltration chromatography, yielding two
clear absorbency peaks as shown in Fig. 1. The full
sequence of the C-terminal region was obtained after
N-terminal amino acid sequencing of the larger frag-
ment (aa 17^43). Following reduction and alkylation
with 4-vinyl pyridine of the uncleaved peptide, the
residues at positions 9 and 14 were identi¢ed as pyr-
idethylated cysteinyl residues, rendering the complete
primary structure of a novel bacteriocin, which was
designated mundticin: KYYGNGVSCNKKGCSV-
DWGKAIGIIGNNSAANLATGGAAGWSK. A ho-
mology search for the entire sequence of mundticin
through the SwissProt database rendered eight other
bacteriocins of LAB with a highly conserved
YGNGV motif near the N-terminus (see Table 1).
This motif indicated that mundticin belongs to the
class IIa bacteriocins of LAB [8].
Fig. 3. E¡ect of mundticin on the membrane potential (vi) of
energized, nigericin-treated whole cells of L. monocytogenes
LDCD81-861 in absence or presence of puri¢ed mundticin: i,
0; ii, 1.4U1033 ; iii, 2.8U1033 ; iv, 1.4U1032 ; v, 0.14 Wg mund-
ticin/ml. The vi was measured with the £uorescent probe DiS-
C35. The absence of the vi was established at 0.05 arbitrary
£uorescence units by the addition of valinomycin (2 WM).
Fig. 4. Intracellular ATP concentrations (dots) or extracellular
ATP concentrations (squares) of L. monocytogenes LDCD81-
861 cells after the addition of glucose at t = 0 (gluc; ¢nal con-
centration 0.5% w/v), in the absence (aE, control) or presence
(bF) of mundticin (0.14 Wg/ml). The values represent the aver-
age of duplicate determinations.
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The average mass of mundticin as determined by
electronspray mass spectrometry was 4287.21 þ 0.59
Da (Fig. 2), which fully agrees with a calculated mass
of 4287.8 in the presence of one disul¢de bridge,
linking the cysteine residues at positions 9 and 14.
3.2. Antimicrobial spectrum of mundticin
Mundticin was found to inhibit the growth of a
wide range of Gram-positive bacteria at nanomolar
concentrations. Speci¢cally, this bacteriocin caused a
10 000-fold reduction of viable counts of the patho-
gen L. monocytogenes within 25 or 150 min at a
concentration of 1.0 or 0.1 Wg/ml, respectively, which
demonstrated its vigorous bactericidal action. Fur-
thermore, mundticin prevented the outgrowth of
spores and vegetative cells of toxin-producing strains
of Clostridium botulinum and inhibited the growth of
di¡erent species of LAB (Lactobacillus salivarius, L.
sake, Leuconostoc paramesenteroides, Leuconostoc
mesenteroides, Carnobacterium piscicola, Pediococcus
dextrinicus, P. pentosaseus, Enterococcus faecalis, E.
Fig. 5. Steric representation of the tilted peptide in the bacteriocins (A) mundticin (residues 15^27) and (B) sakacin P (residues 15^26)
at a lipid (upper)/water (lower) interface. The peptides are orientated at an angle of 40‡ and 45‡, respectively.
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hirae, and Listeria inocua). We did not observe activ-
ity against Gram-negative bacteria and fungi.
3.3. Mundticin targets the cytoplasmic membrane and
dissipates the vi
To investigate the e¡ect of mundticin on the cyto-
plasmic membrane, the membrane potential (vi) of
whole cells of L. monocytogenes LDCD81-861 was
measured after exposure to the puri¢ed bacteriocin.
At increasing bacteriocin concentrations, a more rap-
id vi dissipation was observed in conjunction with a
lower ¢nal membrane potential (Fig. 3). The addition
of mundticin to energized cells of the same strain at a
concentration that caused the complete dissipation of
the vi resulted in an almost complete loss of intra-
cellular ATP within 10 min, in absence of ATP leak-
age (Fig. 4). The elimination of the growth of L.
monocytogenes was achieved at 7 ng/ml (=MIC),
which is a lower concentration than required for
full dissipation of the vi.
3.4. Identi¢cation of the oblique-orientated peptides in
class IIa bacteriocins
The sequence of mundticin and homologous bac-
teriocins was scanned to identify a peptide meeting
the criteria of an oblique-orientated K-helical peptide
(see Section 2). This analysis identi¢ed oblique-ori-
entated peptides in these bacteriocins, which were
predicted to insert into the hydrophobic^hydrophilic
interface at an approximate angle of 40‡ relative to a
lipid^water interface, due to the hydrophobicity gra-
dient between the N-terminal and the C-terminal end
of the peptide (Table 2). Fig. 5 shows the most prob-
able conformation of the bacteriocin helical peptides
at a hydrophobic/hydrophilic interface for mundticin
(residues 15^27) and sakacin P (residues 15^26), and
illustrates how these regions can perturb the regular
parallel orientation of phospholipids.
We also veri¢ed the presence of oblique helical
peptides in hybrid class IIa bacteriocins as described
by Fimland et al. [15]. These investigators con-
structed hybrid class IIa bacteriocins by combining
the N-terminal parts (residues 1^21) of pediocin PA-
1, sakacin P and curvacin A (sakacin A) with the C-
terminal parts (residues 22 to end) of these bacterio-
cins, rendering Ped-Sak, Sak-Ped, Cur-Sak and Sak-
Cur. Each of the hybrid bacteriocins had an antimi-
crobial spectrum similar to the parent C-terminal
bacteriocin. However, only Ped-Sak was as potent
as the parent bacteriocin, whereas the other hybrids
had signi¢cantly lower activities (Table 3 and [15]).
Interestingly, the construction of these hybrid bacter-
iocins involved the regions that encompassed their
predicted K-helical domains. Our analysis revealed
that only Ped-Sak had a hydrophobic oblique pep-
tide with an angle of insertion of 45‡, which could
explain retained activity. The hydrophobic K-helical
regions of Sak-Ped and Sak-Cur had angles of inser-
tion of 25 and 0‡, respectively, indicating a near par-
allel or full parallel orientation to the hydrophobic^
Table 2
Sequence and properties of the oblique helical peptides identi¢ed in class IIa bacteriocins
Bacteriocina Sequence of K-helical
region
Residues % Homology % Identity Ho WH Angle of
insertion (‡)
Mundticin SVDWGKAIGIIGN 15^27 100 100 0.37 0.37 40
Piscicolin 126 TVDWSKAIGIIGN 15^27 100 85 0.33 0.33 45
Sakacin P TVDWGTAIGNIG 15^26 83 75 0.42 0.41 35
Pediocin PA-1 SVDWGKATTCIIN 15^27 77 69 0.20 0.20 30
Leucocin A SVNWGEAFSAGVH 15^27 69 37 0.32 0.26 30
Mesentericin Y105 SVNWGEAASAGIH 15^27 69 37 0.30 0.23 35
Carnobacteriocin B2 SVNWGQAFQERYT 15^27 54 38 30.11 0.25 42
Carnobacteriocin BM1 WVNKAENKQAITG 16^28 46 15 30.01 0.15 53
Sakacin A, Curvacin A WVNRGEATQSIIG 16^28 38 31 0.09 0.19 32
The mean hydrophobicity (Ho) and the hydrophobic moment (WH) of the peptide was computed using the Eisenberg consensus scale
[33]. The angle of insertion in a lipid bilayer was calculated according to Brasseur [21]. The amphiphilic K-helical peptides of the three
bacteriocins with the lowest homology to mundticin were calculated to have an oblique orientation; however, their Ho was low.
aSwissProt accession numbers are listed in Table 1.
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hydrophilic interface. In addition, Cur-Sak contained
a helical peptide with an angle of insertion of 70‡
that resembles a perpendicular orientation (Table 3).
4. Discussion
This report describes the isolation and identi¢ca-
tion of a novel antimicrobial peptide from the Gram-
positive bacterium E. mundtii. To our knowledge,
this is the ¢rst report on bacteriocin production by
this organism. The secreted antimicrobial compound,
designated mundticin, belongs to the class IIa bacter-
iocins of LAB [8] and was shown to exhibit antimi-
crobial activity towards a broad range of Gram-pos-
itive bacteria, among which C. botulinum and L.
monocytogenes. The action of mundticin on L. mono-
cytogenes involves the dissipation of the membrane
potential and a depletion of the intracellular ATP
pools of this organism, in absence of ATP leakage.
By computer modelling, we have studied the orienta-
tion of predicted K-helical regions of mundticin and
homologous class IIa bacteriocins at a hydrophobic^
hydrophilic interface.
Mundticin is a positively charged, hydrophobic, 43
amino acid peptide, with a highly conserved
YGNGV motif at positions 3^7. Amino acid se-
quence analysis of mundticin in conjunction with
its molecular mass indicated the presence of one di-
sul¢de bridge between Cys9 and Cys14, and the ab-
sence of further post-translational modi¢cations.
These two cysteines were also present in homologous
class IIa bacteriocins. Although the presence of a
disul¢de bridge between these two cysteines was re-
quired for the activity of pediocin PA-1 and mesen-
terocin Y105 [13,16], it was reported not to be re-
quired for activity of leucocin A and carnobacteriocin
B2 [14,36]. Except for residues 34^36, the sequence
similarities between mundticin and the other class IIa
bacteriocins were high at the N-terminal region, but
low for the remaining 22 residues.
Mundticin was shown to inhibit the growth of a
broad spectrum of bacteria, including the toxin pro-
ducing Clostridium botulinum and L. monocytogenes,
a Gram-positive bacterium that can cause severe in-
fections of the central nervous system [27]. In addi-
tion to its broad antimicrobial spectrum, mundticin
has a number of other favorable characteristics for
application as a natural antimicrobial agent in foods,
namely, its good solubility in water, and its stability
over a wide pH and temperature range. However, the
application of mundticin in foods will require detailed
toxicity studies. Also, the safety of applying mundti-
cin-producing E. mundtii in foods needs to be further
investigated, since Enterococci do not have a gener-
ally recognized as safe (GRAS) status [37].
The bactericidal e¡ect of mundticin on cells of L.
monocytogenes was shown to be related to a rapid loss
of the membrane potential, which indicated the dis-
sipation of ionic gradients as a result of pore-forma-
tion. In absence of ATP leakage, the observed reduc-
tion of the ATP pool size can be explained by the
accelerated consumption of ATP to regenerate the
decreased PMF and/or by a shift in the ATP hydrol-
ysis equilibrium resulting from phosphate e¥ux [38].
The absence of ATP e¥ux furthermore indicates that
the size exclusion limit of mundticin-induced pores is
smaller than 500 Da. The action of mundticin hereby
resembles that of the class IIa bacteriocins pediocin
PA-1 [39] and mesenterocin Y105 [40].
The results of our computer modelling studies in-
dicate that mundticin and the other YGNGV bacter-
iocins contain obliquely orientated K-helical peptide
regions. The presence of these oblique peptides may
Table 3
Sequence and properties of the oblique helical peptides identi¢ed in hybrid class IIa bacteriocins reported by Fimland et al. [15]
Hybrid bacteriocina Sequence of K-helical region Ho WH Angle of
insertion (‡)
Activity of hybrid bacteriocin
compared to native bacteriocinsa
Ped^Sak SVDWGKAIGNIGN 0.2 0.45 45 100%
Sak^Ped TVDWGTATTCIIN 0.32 0.23 25 6 1%
Sak^Cur TVDWGTATQSIIG 0.32 0.2 0 6 1%
Cur^Sak WVNRGEAIGNIGN 0.09 0.31 70 6 2%
aThe abbreviations of the hybrid bacteriocins are described in [15] and Section 3. The full sequence of these hybrid bacteriocins and
their exact activities against various indicator strains are described in [15].
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contribute to destabilization of the phospholipid bi-
layers, thereby facilitating the insertion of bacteriocin
molecules in the cytoplasmic membrane of the target
organism. The suggested role of the oblique peptides
in the activity of the class IIa bacteriocins was sup-
ported by our analysis of hybrid bacteriocins that
were constructed by Fimland et al. [15]: only the
hybrid molecule that had antimicrobial activity sim-
ilar to the parent bacteriocins was predicted to con-
tain an oblique peptide. However, experimental stud-
ies need to be performed to con¢rm the proposed
relevance of oblique helical peptides in the action
of YGNGV bacteriocins. To this end, rational design
of molecules can be enabled by the presented com-
puter analysis.
In conclusion, we here report the puri¢cation and
identi¢cation of mundticin, a novel class IIa bacter-
iocin of LAB, and its action on the cytoplasmic
membrane of target strains was demonstrated. Com-
puter analysis indicated that members of this class
contain K-helical regions with an oblique orientation
at a hydrophobic^hydrophilic interface that may per-
turb phospholipid bilayers. Furthermore, mundticin
was shown to have a broad spectrum of activity and
properties that make it a good candidate for appli-
cation as a natural antimicrobial compound in foods.
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